GB202011652D0 - Polypeptide panels and uses thereof - Google Patents

Polypeptide panels and uses thereof

Info

Publication number
GB202011652D0
GB202011652D0 GBGB2011652.1A GB202011652A GB202011652D0 GB 202011652 D0 GB202011652 D0 GB 202011652D0 GB 202011652 A GB202011652 A GB 202011652A GB 202011652 D0 GB202011652 D0 GB 202011652D0
Authority
GB
United Kingdom
Prior art keywords
polypeptide
panels
polypeptide panels
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2011652.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB2011652.1A priority Critical patent/GB202011652D0/en
Publication of GB202011652D0 publication Critical patent/GB202011652D0/en
Priority to PCT/GB2021/051927 priority patent/WO2022023727A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GBGB2011652.1A 2020-07-28 2020-07-28 Polypeptide panels and uses thereof Ceased GB202011652D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2011652.1A GB202011652D0 (en) 2020-07-28 2020-07-28 Polypeptide panels and uses thereof
PCT/GB2021/051927 WO2022023727A1 (en) 2020-07-28 2021-07-27 Polypeptide panels and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2011652.1A GB202011652D0 (en) 2020-07-28 2020-07-28 Polypeptide panels and uses thereof

Publications (1)

Publication Number Publication Date
GB202011652D0 true GB202011652D0 (en) 2020-09-09

Family

ID=72339382

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2011652.1A Ceased GB202011652D0 (en) 2020-07-28 2020-07-28 Polypeptide panels and uses thereof

Country Status (2)

Country Link
GB (1) GB202011652D0 (en)
WO (1) WO2022023727A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113234676A (en) * 2021-04-13 2021-08-10 华南农业大学 Method for promoting duck T cell proliferation and application thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240012394A (en) * 2021-05-20 2024-01-29 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 SARS-CoV-2 polypeptide
WO2023178395A1 (en) * 2022-03-25 2023-09-28 Fundação Zerbini Combination of epitopes and use thereof, vaccine construct, method of inducing an immune response, method for the identification of epitopes
EP4283297A1 (en) * 2022-05-27 2023-11-29 Institut d'Investigacions Biomèdiques August Pi i Sunyer Test for detecting cellular immune response to sars-cov-2

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090017069A1 (en) * 2000-06-29 2009-01-15 Lipid Sciences, Inc. SARS Vaccine Compositions and Methods of Making and Using Them
EP1633775A2 (en) * 2003-06-13 2006-03-15 Crucell Holland B.V. Antigenic peptides of sars coronavirus and uses thereof
WO2011138032A2 (en) * 2010-05-05 2011-11-10 Artemev, Timur Universal influenza vaccines and methods for their generation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113234676A (en) * 2021-04-13 2021-08-10 华南农业大学 Method for promoting duck T cell proliferation and application thereof
CN113234676B (en) * 2021-04-13 2022-12-13 华南农业大学 Method for promoting duck T cell proliferation and application thereof

Also Published As

Publication number Publication date
WO2022023727A1 (en) 2022-02-03

Similar Documents

Publication Publication Date Title
GB202011652D0 (en) Polypeptide panels and uses thereof
IL284633A (en) Polypeptides comprising modified il-2 polypeptides and uses thereof
SG11202107269XA (en) Modified cell expansion and uses thereof
IL287781A (en) Clec12a-binding polypeptides and uses thereof
GB202006376D0 (en) Recombinant sars-cov-2 polypeptides and uses
IL287782A (en) Cd33-binding polypeptides and uses thereof
EP3909975A4 (en) Novel polypeptide and therapeutic uses thereof
GB201819200D0 (en) Polypeptide and uses thereof
IL312553A (en) Novel crispr-cas12i systems and uses thereof
PL4189193T3 (en) Panel and covering
GB202012804D0 (en) Agrin polypeptide and uses thereof
GB2600592B (en) Polypeptide and use thereof
GB2603645B (en) Polypeptides having anti-senescent effects and uses thereof
IL313778A (en) Lilrb polypeptides and uses thereof
IL312918A (en) Staple-containing polypeptides and application thereof
IL311185A (en) Mog-binding proteins and uses thereof
GB202109082D0 (en) Polypeptides and uses thereof
EP4175970A4 (en) Peptides and uses thereof
ZA202105634B (en) Panel and covering comprising the same
EP4188659A4 (en) Bamboo-hybrid structural panels and structural sections
EP4023663A4 (en) Polypeptide and application thereof
GB202019817D0 (en) Ligand-binding polypeptides and uses thereof
GB202002010D0 (en) Microtopographies and uses thereof
GB202018733D0 (en) Polypeptides and uses thereof
GB202100996D0 (en) Ezrin-derived peptides and uses

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)